Novel antiplatelet agent ticagrelor in the management of acute coronary syndrome. - Wikidata - awgldk - TriplyDB

Novel antiplatelet agent ticagrelor in the management of acute coronary syndrome.

Novel antiplatelet agent ticagrelor in the management of acute coronary syndrome.

http://www.wikidata.org/entity/Q37825548

about

Historical lessons in translational medicine: cyclooxygenase inhibition and P2Y12 antagonism.Ticagrelor: positive, negative and misunderstood properties as a new antiplatelet agent.

P2860

Q34536091-103A500F-A854-477D-A688-5A5DB21591E1 Q38099380-D69E2C62-8EDF-4075-85FC-EB65E305112B

P2860

Novel antiplatelet agent ticagrelor in the management of acute coronary syndrome.

http://www.wikidata.org/entity/Q37825548

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 28 December 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Novel antiplatelet agent ticagrelor in the management of acute coronary syndrome.

@en

Novel antiplatelet agent ticagrelor in the management of acute coronary syndrome.

@nl

type

label

Novel antiplatelet agent ticagrelor in the management of acute coronary syndrome.

@en

Novel antiplatelet agent ticagrelor in the management of acute coronary syndrome.

@nl

prefLabel

Novel antiplatelet agent ticagrelor in the management of acute coronary syndrome.

@en

Novel antiplatelet agent ticagrelor in the management of acute coronary syndrome.

@nl

P1433

Q37825548-9C735DE5-F6D7-45C5-8BE9-9CA47EA94822

P1476

Q37825548-E503D50B-21C5-4408-9085-3D73B48C6834

P2093

Q37825548-4B7A6027-F785-4800-B9E6-B88B963EC91C

Q37825548-A917CB59-341D-448A-9A8F-018209440E31

Q37825548-D75527B0-A33B-4487-A0AE-242CA575C4F5

P2860

Q37825548-01640CFA-7A3A-4321-B2B9-2F325151BD27

Q37825548-03ACB1DD-38AD-4423-95AD-265887F203C8

Q37825548-0870D6FB-0D76-4034-B4D5-9D873E1215F6

Q37825548-09FEC97E-1B92-411A-BC83-7D6F2CD99508

Q37825548-1AF4A082-1384-478F-8864-E748E5EC3143

Q37825548-36303244-8431-49C6-8D90-F9E6E69CE0B9

Q37825548-3CBCBEF5-5B7B-4871-BBC6-CD330D0655D9

Q37825548-42D54AC4-BBEE-4E9C-BC00-00F270A1AFE8

Q37825548-4A36C9FE-D98C-40E3-AF58-5C96FB303493

Q37825548-4FF0AD56-A122-4921-AF12-457500A4A0F4

P304

Q37825548-9F5BDA99-2A4B-4FDF-83B1-B5DFD2B375D6

P31

Q37825548-69316206-5c8e-4abc-8e26-73f8c4026fc6

Q37825548-7F95AEC5-54C7-44C8-97DE-6B8C1803A630

P356

Q37825548-CD7368C6-D173-4E45-85F0-E96E551090A0

P433

Q37825548-0DB7BC1D-2903-48B2-9B50-EE94666E55D9

P478

Q37825548-5E81BE41-DE2F-47CC-9B16-1ABE80EF6BFE

P577

Q37825548-68A54165-5976-45FC-8706-A72FE09557CA

P698

Q37825548-52FEA7A9-FA37-42A3-BDBD-53437BC48767

P356

J.1540-8183.2010.00613.X

P1433

Journal of Interventional Cardiology

P1476

Novel antiplatelet agent ticagrelor in the management of acute coronary syndrome.

@en

P2093

Mehrnoosh Hashemzadeh

http://www.w3.org/2001/XMLSchema#string

Mohammad Reza Movahed

http://www.w3.org/2001/XMLSchema#string

Radhakrishnan Ramaraj

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin

Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease

BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy

Antithrombotic therapy for coronary artery disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

Thrombolysis and adjunctive therapy in acute myocardial infarction: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

Thrombin-initiated platelet activation in vivo is vWF independent during thrombus formation in a laser injury model

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions.

Abnormally high thromboxane biosynthesis in homozygous homocystinuria. Evidence for platelet involvement and probucol-sensitive mechanism

P304

199-207

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1540-8183.2010.00613.X

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P577

2010-12-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21198849

http://www.w3.org/2001/XMLSchema#string